Altera Biosciences is a preclinical-stage biotechnology company developing a universal donor cell platform.
Altera Biosciences has raised $1.6M in total funding. The most recent round was Pre-Seed. The last funding was announced in July 2025.
Altera Biosciences's investors include E Squared Investments, OneBio Venture Studio.
Altera Biosciences is headquartered in Wilmington, United States.
Altera Biosciences is a preclinical-stage biotechnology company developing a universal donor cell platform.
Altera Biosciences is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Altera Biosciences — Funding & Investors." VCBacked, July 31, 2025, https://www.vcbacked.co/company/altera-biosciences. Accessed August 13, 2026.
VCBacked. (2025). Altera Biosciences — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/altera-biosciences
{{cite web |title=Altera Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/altera-biosciences |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated